Treatment of experimental breast cancer with combination of IL-12 gene therapy and anti-VEGFR-2 antibody

被引：0
|
作者：
Rakhmilevich, AL
Hooper, AT
Imboden, M
Hicklin, DJ
Sondel, PM
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] ImClone Syst Inc, New York, NY USA
来源：
CANCER GENE THERAPY | 2003年 / 10卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
102
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [31] ANTITUMOR EFFECTS OF INTERLEUKIN-12 (IL-12) - APPLICATIONS FOR THE IMMUNOTHERAPY AND GENE-THERAPY OF CANCER
    TAHARA, H
    LOTZE, MT
    GENE THERAPY, 1995, 2 (02) : 96 - 106
  • [32] Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure
    Suzuki, Ryo
    Namai, Eisuke
    Oda, Yusuke
    Nishiie, Norihito
    Otake, Shota
    Koshima, Risa
    Hirata, Keiichi
    Taira, Yuichiro
    Utoguchi, Naoki
    Negishi, Yoichi
    Nakagawa, Shinsaku
    Maruyama, Kazuo
    JOURNAL OF CONTROLLED RELEASE, 2010, 142 (02) : 245 - 250
  • [33] ADENOVIRUS IL-12 AND DOCETAXEL IN COMBINATION WITH ANTI-PD1 AS AN EFFECTIVE TREATMENT STRATEGY FOR TNBC
    Qian, Wei
    Zhou, Jianying
    Rosato, Roberto
    Chang, Jenny
    Anselme, Ann
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A266 - A266
  • [34] Demonstration of systemic antitumor immunity via intratumoral regulated expression of IL-12 as a gene therapy approach to treatment of cancer
    Barrett, John A.
    Chan, Tim
    Cai, Hongliang
    Miao, John
    Krishnan, Suma
    Lebel, Francois
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [35] IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside
    Wigginton, JM
    Wiltrout, RH
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (05) : 513 - 524
  • [36] Combination gene therapy of IL-12 and allogeneic MHC class I gene via stimulating NK cytolytic activity
    Yoon, SJ
    Heo, DS
    Kang, JO
    Kim, NK
    ANTICANCER RESEARCH, 1999, 19 (5B) : 4337 - 4342
  • [37] Gene Therapy with IL-2 and IL-12 in Murine CT26 Colon Carcinoma
    Komel, Tilen
    Bosnjak, Masa
    Brezar, Simona Kranjc
    Dolinar, Klemen
    Pirkmajer, Sergej
    Sersa, Gregor
    Cemazar, Maja
    MOLECULAR THERAPY, 2022, 30 (04) : 318 - 318
  • [38] Transfection of IL-2 and/or IL-12 genes into spleen in treatment of rat liver cancer
    You, Tian-Geng
    Wang, Hong-Shun
    Yang, Jia-He
    Qian, Qi-Jun
    Fan, Rui-Fang
    Wu, Meng-Chao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (15) : 2190 - 2194
  • [39] Erratum: IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer
    H Wang
    G Yang
    T L Timme
    T Fujita
    K Naruishi
    A Frolov
    M K Brenner
    D Kadmon
    T C Thompson
    Cancer Gene Therapy, 2007, 14 : 873 - 874
  • [40] Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF combination therapy
    Grant, JF
    Iwasawa, T
    Griffith, TS
    Siemens, DR
    Broghammer, EL
    Ratliff, TL
    FASEB JOURNAL, 2005, 19 (05): : A1403 - A1403
12345